SBI HoldingsSBI Holdings, Inc.8473東証プライム証券、商品先物取引業FY ending Mar 2026, consolidated, IFRS

SBI Holdings FY ending Mar 2022 results

About 60% of SBI Holdings's sales come from Financial Services Business, with Investment Business and Crypto-asset Business making up much of the rest.

Out of every ¥100 of sales, about ¥41 is left as operating profit.

Revenue changed +41.1% from the prior year.

What changed from last year

FY ending Mar 2021 → FY ending Mar 2022

Revenue
+41.1%¥541.1B → ¥763.6B
Gross profit
+35.9%¥398.6B → ¥541.8B
Net income attributable to owners
+352.4%¥81.1B → ¥366.9B
Operating cash flow
Loss-¥178.4B → -¥314B

Where the money goes

FY ending Mar 2021 → FY ending Mar 2022

※ Segment revenues include inter-segment sales and are scaled to consolidated revenue

※ Operating income is not disclosed; the chart goes straight to pretax income including investment gains

Where ¥100 of sales goes

For every ¥100 SBI Holdings sells, how much goes where, and how much is kept.

FY ending Mar 2022
Cost of sales
¥29
SG&A
¥30
Operating profit
¥41
Net profit kept
¥48

* This company does not report operating income, so it is calculated as gross profit minus SG&A. Equity-method income and dividends are not included, so net profit can be larger.

Annual margin trends

Gross margin71.0%
FY ending Mar 2020: 69.9%69.9%FY ending Mar 2021: 73.7%73.7%FY ending Mar 2022: 71.0%71.0%FY17FY18FY19FY20FY21FY22
Net margin48.0%
FY ending Mar 2017: 12.4%12.4%FY ending Mar 2018: 13.9%13.9%FY ending Mar 2019: 15.0%15.0%FY ending Mar 2020: 10.2%10.2%FY ending Mar 2021: 15.0%15.0%FY ending Mar 2022: 48.0%48.0%FY17FY18FY19FY20FY21FY22

Aligned fiscal years compare the shares of revenue remaining as gross, core, and net profit. Missing years are left unconnected.

Which businesses earn the money

Revenue by business segment, and the profit each one keeps.

FY ending Mar 2022
  • Financial Services Business¥492.7B
    60%
  • Investment Business¥177.8B
    22%
  • Crypto-asset Business¥55.4B
    7%
  • Other¥43.4B
    5%
  • Non-Financial Business¥21.5B
    3%
  • Asset Management Business¥16.5B
    2%
  • Biotechnology, Healthcare and Medical Informatics Business¥9.22B
    1%

Profit by segment

※ Segments without disclosed profit are drawn entirely as costs

※ Segment figures include inter-segment sales and do not sum to the company total

Sources

Show source documents (6)
  • EDINET (FSA Japan)

    有価証券報告書-第28期(2025/04/01-2026/03/31)

    ID S100YK3R2026-06-25Open
  • EDINET (FSA Japan)

    有価証券報告書-第27期(2024/04/01-2025/03/31)

    ID S100W7392025-06-26Open
  • EDINET (FSA Japan)

    有価証券報告書-第26期(2023/04/01-2024/03/31)

    ID S100TTO42024-06-27Open
  • EDINET (FSA Japan)

    有価証券報告書-第25期(2022/04/01-2023/03/31)

    ID S100R9J72023-06-30Open
  • EDINET (FSA Japan)

    有価証券報告書-第24期(令和3年4月1日-令和4年3月31日)

    ID S100OSES2022-07-27Open
  • EDINET (FSA Japan)

    有価証券報告書-第23期(令和2年4月1日-令和3年3月31日)

    ID S100LU0J2021-06-29Open

Extracted from XBRL: 39 / Derived from other figures: 1

Spotted an error? Report it (corrections keep the original record)

Other periods

Analyze this page with AI

Markdown with figures, units, periods and sources, ready to paste into ChatGPT or Claude.